News
Manuel Ramirez: ”Once we have made the step from the laboratory to the patient, we must return to the laboratory for further progress”
The pediatrician and oncologist Manuel Ramírez explained at a conference in the past IDIBELL June 10 his clinical experience in children with solid tumors treated with the virus ICOVIR 5, designed by the research group on virotherapy of the IDIBELL led by Ramon Alemany, in the Unit of Pediatric Hematology and Oncology of the Hospital Niño Jesús in Madrid where he heads a research group for developing new therapies for children with cancer.
IDIBELL has a new platform that facilitates the use of ultrasequencing technology
IDIBELL has added a new scientific platform which increases applications of Biomark, an equipment purchased a year ago that performs real-time PCR, gene expression, genotyping, and digital analysis of a large number of samples. The new platform, called Access Array System, enables to obtain the number of PCR amplifications needed to sequence the samples with the new technology Next Generation Sequencing System with a great reduction of time and costs.
Researcher Joan Gil wins Valdés-Salas award in applied biomedicine
The head of the research group on apoptosis and cancer of the IDIBELL, and professor of biochemistry and molecular biology at the University of Barcelona, Joan Gil, has been awarded the I Fundación Valdés-Salas Award in Applied Biomedicine. The jury decided unanimously to grant this award to Joan Gil for his research in finding new treatments for leukemia and lymphoma in B cells.
Francisco Sánchez-Madrid: ”The immune cells exchange genetic material”
During the process of immune recognition, T cells and antigen-presenting cells exchange genetic information (microRNA), which allows modify the immune behavior. The researcher of the institute of health research of La Princesa Hospital, in Madrid, Francisco Sánchez-Madrid explained his recent work on processes that lead to the immune response during an IDIBELL seminar on 3rd June in the conference hall of the Duran i Reynals Hospital (ICO).
IDIBELL researcher takes part in sequencing the genome of chronic lymphocytic leukemia
IDIBELL researcher at Catalan Institute of Oncology (ICO) Silvia de Sanjosé has taken part in sequencing the genome of chronic lymphocytic leukemia. The research, led by the researcher of the Institute of Biomedical Research August Pi i Sunyer (IDIBAPS) Elias Campo, is published in the latest issue of the journal Nature. The results of this […]
Christian Dobel: ”aphasic patients can recover language abilities through the mechanisms that allow children to learn to speak”
Patients with aphasia (loss of ability to understand or produce language) are able to recover language skills through the same mechanisms that allow children to learn to speak. Complex activity About Dobel
Fundación Hesperia funds an IDIBELL research project on rare diseases
The Princes of Asturias receive the recipients of the aids in the Palacio de la Zarzuela The research group of neurometabolic diseases of IDIBELL led by the ICREA researcher Aurora Pujol will receive a grant of 45,000 euros for a research project on X -linked adrenoleukodystrophy.
Gianluigi Giannelli: ‘Stop cancer is not enough, we should stop dugs’ side effects too’
The researcher Gianluigi Giannelli of the University of Bari, Italy, focuses its research on studying the molecular mechanisms responsible for the progression of tumors, especially hepatic ones, and the identification of new therapeutic targets. Giannelli explained at a conference in the framework of the seminars IDIBELL, on 20 May that this must be the correct […]
IDIBELL researchers identified a new gene associated with risk of breast cancer
An international study led by researchers at the Institute of Biomedical Research of Bellvitge (IDIBELL) has identified a new gene involved in susceptibility of developing breast cancer. Article’s reference Evidence for a link between TNFRSF11A and risk of Breast Cancer.